Yefei Rong

1.7k total citations
41 papers, 1.3k citations indexed

About

Yefei Rong is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Yefei Rong has authored 41 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 23 papers in Oncology and 14 papers in Cancer Research. Recurrent topics in Yefei Rong's work include Pancreatic and Hepatic Oncology Research (17 papers), Cancer, Hypoxia, and Metabolism (5 papers) and MicroRNA in disease regulation (4 papers). Yefei Rong is often cited by papers focused on Pancreatic and Hepatic Oncology Research (17 papers), Cancer, Hypoxia, and Metabolism (5 papers) and MicroRNA in disease regulation (4 papers). Yefei Rong collaborates with scholars based in China, United States and Pakistan. Yefei Rong's co-authors include Wenchuan Wu, Dansong Wang, Tiantao Kuang, Dayong Jin, Wenhui Lou, Xuefeng Xu, Yuan Fang, Wentao Zhou, Wenhui Lou and Xiaoling Ni and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Immunology and Nature Cell Biology.

In The Last Decade

Yefei Rong

40 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yefei Rong China 20 719 509 469 256 146 41 1.3k
Ying‐Hui Zhu China 20 821 1.1× 281 0.6× 464 1.0× 200 0.8× 76 0.5× 49 1.3k
Zhengtang Chen China 24 835 1.2× 813 1.6× 396 0.8× 345 1.3× 136 0.9× 49 1.6k
Ti Wen China 24 638 0.9× 521 1.0× 319 0.7× 391 1.5× 94 0.6× 48 1.2k
Chang Xian Li China 17 451 0.6× 300 0.6× 266 0.6× 427 1.7× 191 1.3× 29 1.2k
Junhong Zhao China 19 805 1.1× 244 0.5× 469 1.0× 207 0.8× 166 1.1× 32 1.2k
Jinglei Qu China 19 611 0.8× 469 0.9× 297 0.6× 183 0.7× 106 0.7× 50 1.1k
Weihua Ren China 20 661 0.9× 258 0.5× 409 0.9× 150 0.6× 112 0.8× 43 1.1k
Jianghua Shao China 22 838 1.2× 453 0.9× 441 0.9× 227 0.9× 154 1.1× 51 1.4k
Fabiana Conciatori Italy 17 743 1.0× 463 0.9× 309 0.7× 184 0.7× 65 0.4× 23 1.2k
Xiao Qi Wang Hong Kong 22 1.1k 1.5× 629 1.2× 394 0.8× 103 0.4× 89 0.6× 33 1.5k

Countries citing papers authored by Yefei Rong

Since Specialization
Citations

This map shows the geographic impact of Yefei Rong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yefei Rong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yefei Rong more than expected).

Fields of papers citing papers by Yefei Rong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yefei Rong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yefei Rong. The network helps show where Yefei Rong may publish in the future.

Co-authorship network of co-authors of Yefei Rong

This figure shows the co-authorship network connecting the top 25 collaborators of Yefei Rong. A scholar is included among the top collaborators of Yefei Rong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yefei Rong. Yefei Rong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liang, Li, Xiao Wang, Yang You, et al.. (2024). Identification of Novel Tumor Pyroptosis-Related Antigens and Pyroptosis Subtypes for Developing mRNA Vaccines in Pancreatic Adenocarcinoma. Biomedicines. 12(4). 726–726. 4 indexed citations
2.
Zhang, Lei, Yefei Rong, Tiantao Kuang, et al.. (2022). NEDD8-Activating Enzyme Inhibitor MLN4924 Inhibits Both the Tumor Stroma and Angiogenesis in Pancreatic Cancer via Gli1 and REDD1. Digestive Diseases and Sciences. 68(4). 1351–1363. 5 indexed citations
3.
Wang, Huanyu, Wenhui Lou, Dayong Jin, et al.. (2022). PYCR1: A Potential Prognostic Biomarker in Pancreatic Ductal Adenocarcinoma. Journal of Cancer. 13(5). 1501–1511. 6 indexed citations
4.
Han, Xu, Yuan Fang, Pingping Chen, et al.. (2021). Upregulated circRNA hsa_circ_0071036 promotes tumourigenesis of pancreatic cancer by sponging miR-489 and predicts unfavorable characteristics and prognosis. Cell Cycle. 20(4). 369–382. 30 indexed citations
5.
Li, Feng, Peng Yuan, Chunhui Jin, et al.. (2020). piRNA-independent function of PIWIL1 as a co-activator for anaphase promoting complex/cyclosome to drive pancreatic cancer metastasis. Nature Cell Biology. 22(4). 425–438. 54 indexed citations
6.
Zhang, Li, Yue Lv, Yefei Rong, et al.. (2019). Downregulated expression of RACK1 results in pancreatic cancer growth and metastasis. SHILAP Revista de lepidopterología. 2 indexed citations
7.
Kuang, Tiantao, Ning Pu, Yuan Fang, et al.. (2019). TRAF6 regulates YAP signaling by promoting the ubiquitination and degradation of MST1 in pancreatic cancer. Clinical and Experimental Medicine. 19(2). 211–218. 25 indexed citations
8.
Fang, Yuan, Wentao Zhou, Yefei Rong, et al.. (2019). Exosomal miRNA-106b from cancer-associated fibroblast promotes gemcitabine resistance in pancreatic cancer. Experimental Cell Research. 383(1). 111543–111543. 187 indexed citations
9.
Song, Chao, Tianwei Chen, Lan He, et al.. (2019). PRMT1 promotes pancreatic cancer growth and predicts poor prognosis. Cellular Oncology. 43(1). 51–62. 51 indexed citations
10.
Zhang, Lei, Yang Lv, Yefei Rong, et al.. (2019). <p>Downregulated expression of RACK1 results in pancreatic cancer growth and metastasis</p>. OncoTargets and Therapy. Volume 12. 1007–1020. 11 indexed citations
11.
Pu, Ning, Shanshan Gao, Hanlin Yin, et al.. (2019). Cell-intrinsic PD-1 promotes proliferation in pancreatic cancer by targeting CYR61/CTGF via the hippo pathway. Cancer Letters. 460. 42–53. 73 indexed citations
12.
Zhang, Lei, Wenhui Lou, Xuefeng Xu, et al.. (2016). SN38 increases IL-8 expression through the MAPK pathways in HCT8 cells. International Journal of Molecular Medicine. 39(1). 217–222. 9 indexed citations
13.
14.
Rong, Yefei, Wenchuan Wu, Xiaoling Ni, et al.. (2013). Lactate dehydrogenase A is overexpressed in pancreatic cancer and promotes the growth of pancreatic cancer cells. Tumor Biology. 34(3). 1523–1530. 150 indexed citations
15.
Wang, Dansong, Yefei Rong, Wenchuan Wu, & Dayong Jin. (2012). Primary small cell carcinoma of the pancreas: rare type of pancreatic cancer and review of the literatures. World Journal of Surgical Oncology. 10(1). 32–32. 14 indexed citations
16.
Cui, Lei, Yuezhen Deng, Yefei Rong, et al.. (2011). IRF-2 is over-expressed in pancreatic cancer and promotes the growth of pancreatic cancer cells. Tumor Biology. 33(1). 247–255. 27 indexed citations
17.
Rong, Yefei, Dansong Wang, Wenhui Lou, Tiantao Kuang, & Dayong Jin. (2010). Granulocytic sarcoma of the pancreas: A case report and review of the literatures. BMC Gastroenterology. 10(1). 80–80. 18 indexed citations
18.
Rong, Yefei, Dayong Jin, Jianwen Hu, et al.. (2010). Proteomics analysis of serum protein profiling in pancreatic cancer patients by DIGE: up-regulation of mannose-binding lectin 2 and myosin light chain kinase 2. BMC Gastroenterology. 10(1). 68–68. 50 indexed citations
19.
Mao, Zhengfa, Xiaoyan Ma, Yefei Rong, et al.. (2010). Connective tissue growth factor enhances the migration of gastric cancer through downregulation of E‐cadherin via the NF‐κB pathway. Cancer Science. 102(1). 104–110. 41 indexed citations
20.
Rong, Yefei, Dayong Jin, Wenchuan Wu, et al.. (2009). Induction of protective and therapeutic anti-pancreatic cancer immunity using a reconstructed MUC1 DNA vaccine. BMC Cancer. 9(1). 191–191. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ying‐Hui Zhu Breakdown of academic impact, for papers by Zhengtang Chen Breakdown of academic impact, for papers by Ti Wen Breakdown of academic impact, for papers by Chang Xian Li Breakdown of academic impact, for papers by Junhong Zhao Breakdown of academic impact, for papers by Jinglei Qu Breakdown of academic impact, for papers by Weihua Ren Breakdown of academic impact, for papers by Jianghua Shao Breakdown of academic impact, for papers by Fabiana Conciatori Breakdown of academic impact, for papers by Xiao Qi Wang
Rankless by CCL
2026